Phase 2 trials of linifanib (ABT-869) in advanced hepatocellular, renal cell and non-small cell lung cancer: Associations of response by CT or DCE-MRI with patient outcome

被引：1
|
作者：
Toh, Han Chong
Yong, Wei Peng
Wang, Yu-Ning
Tan, Eng-Huat
Kollmannsberger, Christian K.
Devanarayan, Viswanath
Zhang, Ke
Luo, Yanping
Chen, Daniel
Ashton, Edward
Ricker, Justin L.
Carlson, Dawn
Chen, Pei-Jer
机构：
来源：
MOLECULAR CANCER THERAPEUTICS | 2009年 / 8卷 / 12期
关键词：
D O I：
10.1158/1535-7163.TARG-09-A105
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A105
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Design, reporting, and disparities of advanced non-small cell lung cancer phase 3 clinical trials in the era of immunotherapy
    Miyawaki, Isabele Ayumi
    Mitre, Lucas Pari
    de Moraes, Fabio Ynoe
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [42] Acute Renal Failure in a Patient Receiving Anti-VEGF Therapy for Advanced Non-small Cell Lung Cancer
    Zhao, Jing
    Li, Hang
    Wang, Mengzhao
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : 1185 - 1187
  • [43] Two randomised phase III, double blind, placebo controlled trials of thalidomide in patients with advanced non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC)
    Lee, S.
    Rudd, R. M.
    Woll, P. J.
    Ottensmeier, C. H.
    James, L. E.
    Gower, N. H.
    Spiro, S. G.
    Jitlal, M.
    Hackshaw, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [44] Role of ERCC1 variants in response to chemotherapy and clinical outcome of advanced non-small cell lung cancer
    Huang, Shao-jun
    Wang, Yu-fei
    Jin, Zhi-yong
    Sun, Jia-yang
    Guo, Zhan-lin
    TUMOR BIOLOGY, 2014, 35 (05) : 4023 - 4029
  • [45] Repeatability of 18F-FDG PET/CT in Advanced Non-Small Cell Lung Cancer: Prospective Assessment in 2 Multicenter Trials
    Weber, Wolfgang A.
    Gatsonis, Constantine A.
    Mozley, P. David
    Hanna, Lucy G.
    Shields, Anthony F.
    Aberle, Denise R.
    Govindan, Ramaswamy
    Torigian, Drew A.
    Karp, Joel S.
    Yu, Jian Q.
    Subramaniam, Rathan M.
    Halvorsen, Robert A.
    Siegel, Barry A.
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (08) : 1137 - 1143
  • [46] Tumor Response in Patients With Advanced Non-Small Cell Lung Cancer: Perfusion CT Evaluation of Chemotherapy and Radiation Therapy
    Wang, Jianwei
    Wu, Ning
    Cham, Matthew D.
    Song, Ying
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2009, 193 (04) : 1090 - 1096
  • [47] MIMEB: A phase II trial to evaluate FDG-PET/FLT-PET and DCE-MRI for early prediction of efficacy in patients with advanced non-small cell lung cancer treated with erlotinib and bevacizumab.
    Scheffler, Matthias
    Christiaan, Marc
    Bos, Allardt
    Sos, Martin
    Nogova, Lucia
    Mattonet, Christian
    Papachristou, Irini
    Kahraman, Deniz
    Kobe, Carsten
    Boellaard, Ronald
    Lammertsma, Adriaan A.
    Heukamp, Lukas Carl
    Buettner, Reinhard
    Elter, Thomas
    Toepelt, Karin
    Engel-Riedel, Walburga
    Stoelben, Erich
    Neumaier, Bernd
    Dietlein, Markus
    Zander, Thomas
    Wolf, Juergen
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [48] Is PET/CT Response of Prognostic Value in Intensified Definitive Chemoradiation for Locally Advanced Non-small Cell Lung Cancer?
    Poettgen, C.
    Eberhardt, W. E.
    Gauler, T.
    Krbek, T.
    Berkovic, K.
    Abu Jawad, J.
    Welter, S.
    Teschler, H.
    Stamatis, G.
    Stuschke, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S449 - S449
  • [49] Systematic analysis of design and stratification for phase III trials in first-line advanced non-small cell lung cancer
    Komiya, Takefumi
    Perez, Raymond P.
    Erickson, Kirsten D.
    Huang, Chao H.
    THORACIC CANCER, 2016, 7 (01) : 66 - 71
  • [50] Phase II trials of single-agent activity of gemcitabine in patients with advanced non-small cell lung cancer: An overview
    Shepherd, FA
    ANTI-CANCER DRUGS, 1995, 6 : 19 - 25
12345